In-vitro anti-inflammatory and immunomodulatory effects of grepafloxacin in zymogen A- or Staphylococcus aureus-stimulated human THP-1 monocytes

Journal of Infection and Chemotherapy

Volumn 9, Issue 2, 2003, Pages 134-143

  Ives, Timothy J ^a   Schwab, Ute E ^b   Ward, E Stacy ^a   Hall, Iris H ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Grepafloxacin; Inflammation; Monocytes; Phagocytosis

Indexed keywords

ACETYLGLUCOSAMINIDASE; CATHEPSIN D; CYCLIC AMP; ENZYME PRECURSOR; GREPAFLOXACIN; HYDROGEN PEROXIDE; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NITRIC OXIDE; PROTEIN KINASE C; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CELL PH; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA SYNTHESIS INHIBITION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME REPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; LIPID PEROXIDATION; MEDIATOR RELEASE; MONOCYTE; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; RESPIRATORY BURST; STAPHYLOCOCCUS AUREUS;

EID: 0038607786     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-003-0232-Z     Document Type: Article

References (45)

1. Baumann H, Gauldie J. The acute phase response. Immunology Today 1994;15:74-89.
2. Morikawa K, Watabe H, Araake M, Morikawa S. Modulatory effect of antibiotics on cytokine production by human monocytes in vitro. Antimicrob Agents Chemother 1996;40:1366-70.
3. Schlüter D, Deckert M. The divergent role of tumor necrosis factor receptors in infectious diseases. Microbes Infect 2000;2:1285-92.
4. Bailly S, Fay M, Ferrua B, Gougerot-Pocidalo MA. Ciprofloxacin treatment in vivo increases the ex vivo capacity of lipopolysaccharide-stimulated human monocytes to produce IL-1, IL-6 and tumour necrosis factor-alpha. Clin Exp Immunol 1991; 85:331-4.
5. Russell DG. Of microbes and macrophages: entry, survival, and persistence. Curr Opin Immunol 1995;7:479-84.
6. Kadir T, Izzetin FV, Cevikbas A, Johansson CB, Clark P. In vitro effects of clarithromycin on human polymorphonuclear leukocyte functions. Chemother 2000;46:198-302.
7. Hand WL, King-Thompson NL. The entry of antibiotics into human monocytes. J Antimicrob Ther 1989;23:681-9.
8. Pascual A, García I, Ballesta S, Perea EJ. Uptake and intracellular activity of moxifloxacin in human neutrophils and tissue-cultured epithelial cells. Antimicrob Agents Chemother 1999;43:12-5.
9. Niwa M, Hotta K, Kanamori Y, Matsuno H, Kozawa O, Hirota M, et al. Differential uptake of grepafloxacin by human circulating blood neutrophils and those exudated into tissues. Eur J Pharmacol 2001;428:121-6.
10. Taira K, Koga H, Kohno S. Accumulation of a newly developed fluroroquinolone, OPC-17116 by human polymorphonuclear leukocytes. Antimicrob Agents Chemother 1993;37:1877-81.
11. Jonas D, Engels I, Friedhoff C, Spitzmuller B, Daschner FD, Frank U. Efficacy of moxifloxacin, trovafloxacin, clinafloxacin and levofloxacin against intracellular Legionella pneumophilia. J Antimicrob Chemother 2001;47:147-52.
12. Aoki M, Ono Y, Kunii O, Goldstein E. Effect of newer quinolones on the extra- and intra-cellular chemiluminescence response of human polymorphonuclear leucocytes. J Antimicrob Chemother 1994;34:383-90.
13. Labro MT. Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"? Clin Microbiol Rev 2000;13:615-50.
14. Bailly S, Fay M, Roche Y, Gougerot-Pocidalo MA. Effects of quinolones on tumor necrosis factor production by human monocytes. Int J Immunopharmacol 1990;12:31-6.
15. Bailly S, Mahe Y, Ferrua B, Fay M, Tursz T, Wakasugi H, et al. Quinolone-induced differential modulation of IL-1a and IL-1b production by LPS-stimulated human monocytes. Cellular Immunol 1990;128:277-88.
16. Roche Y, Fay M, Gougerot-Pocidalo MA. Effects of quinolones on interleukin 1 production in vitro by human monocytes. Immunopharmacology 1987;13:99-109.
17. Roche Y, Gougerot-Pocidalo MA, Fay M, Etienne D, Forest N, Pocidalo JJ. Comparative effects of quinolones on human mononuclear leucocyte functions. J Antimicrob Chemother 1987;19: 781-90.
18. Hara T, Takemura H, Kanemitsu K, Yamamoto H, Shimada J. Comparative uptake of grepafloxacin and ciprofloxacin by a human monocytic cell line, THP-1. J Infect Chemother 2000;6:162-7.
19. Khan AA, Slifer TR, Araujo FG, Suzuki Y, Remington JS. Protection against lipopolysaccharide-induced death by fluoroquinolones. Antimicrob Agents Chemother 2000;44:3169-73.
20. Khan AA, Slifer TR, Remington JS. Effect of trovafloxacin on production of cytokines by human monocytes. Antimicrob Agents Chemother 1998;42:1713-7.
21. Araujo FG, Slifer TL, Remington JS. Effect of moxifloxacin on secretion of cytokines by human monocytes stimulated with lipopolysaccharides. Clin Microbiol Infect 2002;3:26-30.
22. Ives TJ, Schwab UE, Ward ES, Butts JD, Hall IH. Disposition and functions of clarithromycin in human THP-1 monocytes during stimulated and unstimulated conditions. Res Commun Mol Pathol Pharmacol 2001;110:191-216.
23. Neu HC, Fang W, Gu J-W, Chin N-X. In vitro activity of OPC-17116. Antimicrob Agents Chemother 1993;36:1310-5.
24. Miyashita N, Fukano H, Yoshida K, Niki Y, Matsushima T. In-vitro activity of moxifloxacin and other fluoroquinolones against Chlamydia species. J Infect Chemother 2002;8:115-7.
25. Cook PJ. Andrews JM, Wise R, Honeybourne D, Moudgil H. Concentrations of OPC-17116, a new fluoroquinolone antibacterial, in serum and lung compartments. J Antimicrob Chemother 1995;35:317-26.
26. Ito T, Yano I, Masuda S, Hashimoto Y, Inui K. Distribution characteristics of levofloxacin and grepafloxacin in rat kidney. Pharmacol Res 1999;16:534-9.
27. Child J, Andrews JM, Wise R. Pharmacokinetics and tissue penetration of the new fluoroquinolone grepafloxacin. Antimicrob Agents Chemother 1995;39:513-5.
28. Hirota M, Totsu T, Adachi F, Kamikawa K, Watanabe J, Kanegasaki S, et al. Comparison of antimycobacterial activity of grepafloxacin against Mycobacterium avium with that of levofloxacin: accumulation of grepafloxacin in human macrophages. J Infect Chemother 2001;7:16-21.
29. Niwa M, Kanaamori Y, Hotta K, Matsuno H, Kozawa O, Fujimoto S, et al. Priming by grepafloxacin on respiratory burst of human neutrophils: its possible mecahanism. J Antimicrob Chemother 2002;50:469-78.
30. Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 1980;26:171-6.
31. Delic J, Coppey J, Magdelenat H, Coppey-Moisan M. Impossibilities of acridine orange intercalation in nuclear DNA of living cells. Experimental Cell Res 1991;194:147-53.
32. Golder M, Farkas-Himsley H, Kormendy A. Bacterial phagocytosis monitored by fluorescence and extracellular quenching: ingestion and intracellular killing. Laboratory Med 1983;14:291-4.
33. Styrt B, Klempner MS. Inhibition of neutrophil oxidation metabolism by lysosomotropic weak bases. Blood 1986;67:334-42.
34. 2-dependent bactericidal mechanisms. Chemother 1999;45:268-76.
35. King JM, Srivastava KD, Stefano GB, Bilfinger TV, Bahou WF, Magazine HI. Human monocyte adhesion is modulated by endothelin B receptor-coupled nitric oxide release. J Immunol 1997;158:880-6.
36. Klann E, Roberson ED, Knapp LT, Sweatt JD. A role for super-oxide in protein kinase C activation and induction of long-term potentiation. J Biol Chem 1998;273:4516-22.
37. Hall IH, Wong OT, Simlot S, Miller MC III, Izydore RA. Anti-neoplastic activities and cytotoxicity of 1-acyl and 1,2-diacyl-1,2,4-triazolidine-3,5-diones in murine and human tissue culture cells. Anti-cancer Res 1992;12:1355-62.
38. 4 polymorphonuclear leukocyte inflammatory exudates in rats. Prostaglandin 1984;28:13-27.
39. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4.4th Ed, National Committee for Clinical Laboratory Standards Wayne, PA: 1997.
40. Fietta A, Merlini C, Gialdroni Grassi G. Inhibition of intracellular growth of Staphylococcus aureus by exposure of infected human monocytes to clarithromycin and azithromycin. J Chemother 1997;9:17-22.
41. Allen L-AH, Aderem A. Mechanism of phagocytosis. Curr Opin Immunol 1996;8:36-40.
42. Babior BM. Phagocytes and oxidative stress. Am J Med 2000;109: 33-44.
43. Hotta K, Niwa M, Hirota M, Kanamori Y, Matsumo H, Kozawa O, et al. Regulation of fluoroquinolone uptake by human neutrophils: involvement of mitogen-activated protein kinase. J Antimicrob Chemother 2002;49:953-8.
44. Hashimoto S, Matsumoto K, Gon Y, Maruoka S, Hayashi S, Asai Y, et al. Grepafloxacin inhibits tumor necrosis factor-alpha-induced interleukin-8 expression in human airway epithelial cells. Life Sci 2000;66:PL77-82.
45. McCord JM, Fridovich I. Superoxide dismutase: an enzymatic function for erythrocuprein (hemocuprein). J Biol Chem 1969;244: 6049-55.